Cultured cells convert glucose to lactate, and glutamine is the major source of tricarboxylic
acid (TCA)-cycle carbon, but whether the same metabolic phenotype is found in tumors is less …

The clinical development of drug combinations is typically achieved through trial-and-error
or via insight gained through a detailed molecular understanding of dysregulated signaling …

Virtual and high-throughput screens (HTS) should have complementary strengths and
weaknesses, but studies that prospectively and comprehensively compare them are rare. We …

The perceived and actual burden of false positives in high-throughput screening has
received considerable attention; however, few studies exist on the contributions of distinct …

Background Small molecule modulators of epigenetic processes are currently sought as basic
probes for biochemical mechanisms, and as starting points for development of therapeutic …

Trypanosoma cruzi and Trypanosoma brucei are parasites that cause Chagas’ disease and
African sleeping sickness, respectively. Both parasites rely on essential cysteine proteases …

HIV-1 integrase (IN) is the molecular target of the newly approved anti-AIDS drug raltegravir
(MK-0518, Isentress) while elvitegravir (GS-9137, JTK-303) is in clinical trials. The aims of …

Drug resistance in Plasmodium parasites is a constant threat. Novel therapeutics, especially
new drug combinations, must be identified at a faster rate. In response to the urgent need …

Cyclic GMP-AMP (cGAMP) synthase (cGAS) stimulator of interferon genes (STING) senses
pathogen-derived or abnormal self-DNA in the cytosol and triggers an innate immune …

We report the discovery and medicinal chemistry optimization of a novel series of pyrazole-based
inhibitors of human lactate dehydrogenase (LDH). Utilization of a quantitative high-…